| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Third Department of Medicine, Teikyo University School of Medicine (R.O., K.T.), 34263 Anesaki, Ichihara, Chiba 299-0111; Second Department of Research (M.N., M.A.), Department of Metabolism and Endocrinology (M.A., J.M., Y.To.), Kanto-Teishin Hospital, 59-22 Higashi-Gotanda, Shinagawa, Tokyo 141-0022; and Fourth Department of Internal Medicine, University of Tokyo School of Medicine (N.C., Y.Ta., T.F., S. F), 38-6 Mejirodai, Bunkyo, Tokyo 112-0015, Japan
Address all correspondence and requests for reprints to: Ryo Okazaki, M.D., Third Department of Medicine, Teikyo University School of Medicine, 34263 Anesaki, Ichihara 299-0111, Japan. E-mail: rokazaki{at}med.teikyo-u.ac.jp
Autosomal dominant hypocalcemia (ADH), caused by activating mutations of the calcium-sensing receptor (CaSR), is characterized by hypocalcemia with an inappropriately low concentration of PTH. Among 11 missense mutations of CaSR reported to date in patients with ADH or sporadic hypocalcemia, functional properties of 8 mutant CaSRs were characterized. Here, we describe a novel mutation of CaSR and its functional property in a family with ADH. The 41-yr-old male proband had asymptomatic hypocalcemia with a history of recurrent nephrolithiasis. His father had asymptomatic hypocalcemia, but his mother was normocalcemic. PCR-single strand conformation polymorphism and sequencing revealed that both the proband and the father had a novel heterozygous mutation in CaSR gene that causes lysine to asparagine substitution at codon 47 (K47N), which is in the extracellular domain of CaSR, like 6 of 11 known activating mutations. Using HEK293 cells transfected with wild-type or K47N CaSR complementary DNA, the intracellular Ca2+ concentration was assessed in response to changes in the extracellular Ca2+ concentration. The EC50 of the mutant CaSR for the extracellular Ca2+ concentration was 2.2 mmol/L and was significantly lower than that of wild-type (3.7 mmol/L). These results confirm that this mutation is responsible for ADH in this family. The fact that several inactivating mutations in familial hypocalciuric hypercalcemia occur in amino acid around K47 suggests the importance of the N-terminal portion of the receptor in extracellular Ca sensing.
This article has been cited by other articles:
![]() |
Y. M. Tan, J. Cardinal, A. H. Franks, H.-C. Mun, N. Lewis, L. B. Harris, J. B. Prins, and A. D. Conigrave Autosomal Dominant Hypocalcemia: A Novel Activating Mutation (E604K) in the Cysteine-Rich Domain of the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 605 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konrad and S. Weber Recent Advances in Molecular Genetics of Hereditary Magnesium-Losing Disorders J. Am. Soc. Nephrol., January 1, 2003; 14(1): 249 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, Y. Hasegawa, J. Nakae, K. Nanao, I. Takahashi, T. Tajima, N. Shinohara, and K. Fujieda Hydrochlorothiazide Effectively Reduces Urinary Calcium Excretion in Two Japanese Patients with Gain-of-Function Mutations of the Calcium-Sensing Receptor Gene J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3068 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagase, T. Murakami, T. Tsukada, R. Kitamura, N. Chikatsu, H. Takeo, N. Takata, H. Yasuda, S. Fukumoto, Y. Tanaka, et al. A Family of Autosomal Dominant Hypocalcemia with a Positive Correlation between Serum Calcium and Magnesium: Identification of a Novel Gain of Function Mutation (Ser820Phe) in the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2681 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lienhardt, M. Bai, J.-P. Lagarde, M. Rigaud, Z. Zhang, Y. Jiang, M.-L. Kottler, E. M. Brown, and M. Garabedian Activating Mutations of the Calcium-Sensing Receptor: Management of Hypocalcemia J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5313 - 5323. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Dai, G. Ritchie, D. Kerstan, H. S. Kang, D. E. C. Cole, and G. A. Quamme Magnesium Transport in the Renal Distal Convoluted Tubule Physiol Rev, January 1, 2001; 81(1): 51 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, T. Akatsu, T. Nagase, and E. Ogata Comparison of Hypocalcemic Hypercalciuria between Patients with Idiopathic Hypoparathyroidism and Those with Gain-of-Function Mutations in the Calcium-Sensing Receptor: Is It Possible to Differentiate the Two Disorders? J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4583 - 4591. [Abstract] [Full Text] |
||||
![]() |
D. E. C. COLE and G. A. QUAMME Inherited Disorders of Renal Magnesium Handling J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1937 - 1947. [Abstract] [Full Text] |
||||
![]() |
A. Lienhardt, M. Garabédian, M. Bai, C. Sinding, Z. Zhang, J.-P. Lagarde, J. Boulesteix, M. Rigaud, E. M. Brown, and M.-L. Kottler A Large Homozygous or Heterozygous In-Frame Deletion within the Calcium-Sensing Receptor's Carboxylterminal Cytoplasmic Tail That Causes Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1695 - 1702. [Abstract] [Full Text] |
||||
![]() |
A. A. Jensen, T. A. Spalding, E. S. Burstein, P. O. Sheppard, P. J. O'Hara, M. R. Brann, P. Krogsgaard-Larsen, and H. Brauner-Osborne Functional Importance of the Ala116-Pro136 Region in the Calcium-sensing Receptor. CONSTITUTIVE ACTIVITY AND INVERSE AGONISM IN A FAMILY C G-PROTEIN-COUPLED RECEPTOR J. Biol. Chem., September 15, 2000; 275(38): 29547 - 29555. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |